CCN2 and breast cancer: In comparing with CTGF, TNFR1 has been extensively studied to mediate the function of TNF-α in promoting breast cancer growth, and blockage of TNFR1 with specific antibodies was enough to impair TNF-α signaling and biological effects [48].